Similar articles for PMID: 11060337

Year	Number of Results
1995	1
1996	4
1997	11
1998	27
1999	22
2000	36
2001	20
2002	2
2003	2
2004	1
2005	3
2006	4
2007	2
2008	2
2010	3
2017	1
2024	0

1

Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers.

Phillips KA. Phillips KA. J Clin Oncol. 2000 Nov 1;18(21 Suppl):107S-12S. J Clin Oncol. 2000. PMID: 11060337 Review.

2

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

Palacios J, Honrado E, Osorio A, Cazorla A, Sarrió D, Barroso A, Rodríguez S, Cigudosa JC, Diez O, Alonso C, Lerma E, Sánchez L, Rivas C, Benítez J. Palacios J, et al. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3606-14. Clin Cancer Res. 2003. PMID: 14506147

3

A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.

Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen L. Machácková E, et al. Cas Lek Cesk. 2000 Oct 11;139(20):635-7. Cas Lek Cesk. 2000. PMID: 11192759

4

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.

Armes JE, Trute L, White D, Southey MC, Hammet F, Tesoriero A, Hutchins AM, Dite GS, McCredie MR, Giles GG, Hopper JL, Venter DJ. Armes JE, et al. Cancer Res. 1999 Apr 15;59(8):2011-7. Cancer Res. 1999. PMID: 10213514

5

Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women.

Noguchi S, Kasugai T, Miki Y, Fukutomi T, Emi M, Nomizu T. Noguchi S, et al. Cancer. 1999 May 15;85(10):2200-5. Cancer. 1999. PMID: 10326698

6

BRCA-associated breast cancer: absence of a characteristic immunophenotype.

Robson M, Rajan P, Rosen PP, Gilewski T, Hirschaut Y, Pressman P, Haas B, Norton L, Offit K. Robson M, et al. Cancer Res. 1998 May 1;58(9):1839-42. Cancer Res. 1998. PMID: 9581822

7

TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.

Greenblatt MS, Chappuis PO, Bond JP, Hamel N, Foulkes WD. Greenblatt MS, et al. Cancer Res. 2001 May 15;61(10):4092-7. Cancer Res. 2001. PMID: 11358831

8

Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

Tirkkonen M, Johannsson O, Agnarsson BA, Olsson H, Ingvarsson S, Karhu R, Tanner M, Isola J, Barkardottir RB, Borg A, Kallioniemi OP. Tirkkonen M, et al. Cancer Res. 1997 Apr 1;57(7):1222-7. Cancer Res. 1997. PMID: 9102202

9

The Brca1 and Brca2 proteins and tumor pathogenesis.

Ingvarsson S. Ingvarsson S. Anticancer Res. 1999 Jul-Aug;19(4B):2853-61. Anticancer Res. 1999. PMID: 10652564

10

The "portrait" of hereditary breast cancer.

Lacroix M, Leclercq G. Lacroix M, et al. Breast Cancer Res Treat. 2005 Feb;89(3):297-304. doi: 10.1007/s10549-004-2172-4. Breast Cancer Res Treat. 2005. PMID: 15754129 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

139 results

Results by year